Mark Radzyner
Impact in
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Surgical Treatments
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 3
- Pancreatic and Hepatic Oncology Research 1
-
- Economic and Financial Impacts of Cancer 3
- Health Systems, Economic Evaluations, Quality of Life 2
- Co-authors
- David M. Rubin (10 shared papers)Murray F. Brennan (3 shared papers)James Dougherty (1 shared paper)Edward L. Hannan (1 shared paper)Yuman Fong (1 shared paper)Mithat Gönen (1 shared paper)David G. Pfister (4 shared papers)Peter B. Bach (4 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Cancer (2 papers)Annals of Surgery (1 paper)JAMA Oncology (1 paper)Gastroenterology (1 paper)
- Partner nations
- United StatesSwitzerlandSpain
In The Last Decade
Mark Radzyner
13 papers receiving 797 citations
Peers
Comparison fields: 5 of 69
- Oncology 273
- Hepatology 51
- Pulmonary and Respiratory Medicine 176
- Surgery 166
- Cardiology and Cardiovascular Medicine 41
Countries citing papers authored by Mark Radzyner
This map shows the geographic impact of Mark Radzyner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Radzyner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Radzyner more than expected).
Fields of papers citing papers by Mark Radzyner
This network shows the impact of papers produced by Mark Radzyner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Radzyner. The network helps show where Mark Radzyner may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Radzyner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 314 | |
| 2 | 2005 | 303 | |
| 3 | 2015 | 96 | |
| 4 | 1983 | 35 | |
| 5 | 2001 | 29 | |
| 6 | 2009 | 18 | |
| 7 | Effects of glucagon, vasoactive intestinal peptide (VIP) and lysine-vasopressine on villous microcirculation and superior mesenteric artery blood flow of the rat. | 1979 | 6 |
| 8 | 2019 | 5 | |
| 9 | 2004 | 3 | |
| 10 | 2001 | 1 | |
| 11 | 2018 | 1 | |
| 12 | 2019 | 1 | |
| 13 | 1994 | 1 |
About Mark Radzyner
Mark Radzyner is a scholar working on Oncology, Economics and Econometrics, Cellular and Molecular Neuroscience, Epidemiology and Surgery, having authored 13 papers that have together received 813 indexed citations. Recurring topics across this work include Economic and Financial Impacts of Cancer (3 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), Neuropeptides and Animal Physiology (2 papers), Multiple and Secondary Primary Cancers (1 paper), Pancreatic and Hepatic Oncology Research (1 paper), Surgical Simulation and Training (1 paper), Cardiac, Anesthesia and Surgical Outcomes (1 paper) and Pharmaceutical industry and healthcare (1 paper). The work is most often cited by research in Oncology (273 citations), Hepatology (51 citations), Pulmonary and Respiratory Medicine (176 citations), Surgery (166 citations) and Cardiology and Cardiovascular Medicine (41 citations). Mark Radzyner has collaborated with scholars based in United States, Switzerland and Spain. Frequent co-authors include David M. Rubin, Murray F. Brennan, James Dougherty, Edward L. Hannan, Yuman Fong, Mithat Gönen, David G. Pfister, Peter B. Bach, Ushma S. Neill and Elena B. Elkin. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Annals of Surgery, JAMA Oncology and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.